Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?

Author： Li Zhe   Li Qin   Wu Jun   Wang Manyuan   Yu Junxian  

Publisher： MDPI

E-ISSN： 1420-3049|21|10|1331-1331

ISSN： 1420-3049

Source： Molecules, Vol.21, Iss.10, 2016-10, pp. : 1331-1331

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What Do We Know about Opioids and the Kidney?

By Mallappallil Mary   Sabu Jacob   Friedman Eli A.   Salifu Moro  

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 223-223

MDPI

Access to resources Recommend Favorite

Dairy Fats and Cardiovascular Disease: Do We Really Need to Be Concerned?

By Lordan Ronan   Tsoupras Alexandros   Mitra Bhaskar   Zabetakis Ioannis  

Foods, Vol. 7, Iss. 3, 2018-03 ,pp. : 29-29

MDPI

Access to resources Recommend Favorite

Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?

By Ferlazzo Nadia   Cirmi Santa   Calapai Gioacchino   Ventura-Spagnolo Elvira   Gangemi Sebastiano   Navarra Michele  

Molecules, Vol. 21, Iss. 10, 2016-09 ,pp. : 1273-1273

MDPI

Access to resources Recommend Favorite

What Do We Know about the Role of miRNAs in Pediatric Sarcoma?

By Kelly Lorna C.   Lázaro Antonio   O’Sullivan Maureen J.  

International Journal of Molecular Sciences, Vol. 16, Iss. 7, 2015-07 ,pp. : 16593-16621

MDPI

Access to resources Recommend Favorite

Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?

By Pértega-Gomes Nelma   Baltazar Fátima  

International Journal of Molecular Sciences, Vol. 15, Iss. 10, 2014-10 ,pp. : 18333-18348

MDPI

Access to resources Recommend Favorite